Literature DB >> 28408014

Cost-Effectiveness Thresholds in Global Health: Taking a Multisectoral Perspective.

Michelle Remme1, Melisa Martinez-Alvarez2, Anna Vassall2.   

Abstract

Good health is a function of a range of biological, environmental, behavioral, and social factors. The consumption of quality health care services is therefore only a part of how good health is produced. Although few would argue with this, the economic framework used to allocate resources to optimize population health is applied in a way that constrains the analyst and the decision maker to health care services. This approach risks missing two critical issues: 1) multiple sectors contribute to health gain and 2) the goods and services produced by the health sector can have multiple benefits besides health. We illustrate how present cost-effectiveness thresholds could result in health losses, particularly when considering health-producing interventions in other sectors or public health interventions with multisectoral outcomes. We then propose a potentially more optimal second best approach, the so-called cofinancing approach, in which the health payer could redistribute part of its budget to other sectors, where specific nonhealth interventions achieved a health gain more efficiently than the health sector's marginal productivity (opportunity cost). Likewise, other sectors would determine how much to contribute toward such an intervention, given the current marginal productivity of their budgets. Further research is certainly required to test and validate different measurement approaches and to assess the efficiency gains from cofinancing after deducting the transaction costs that would come with such cross-sectoral coordination.
Copyright © 2017 International Society for Pharmacoeconomics and Outcomes Research (ISPOR). Published by Elsevier Inc. All rights reserved.

Keywords:  cofinancing; cost-effectiveness threshold; economic evaluation; multisectoral; public health interventions; social determinants of health

Mesh:

Year:  2017        PMID: 28408014     DOI: 10.1016/j.jval.2016.11.009

Source DB:  PubMed          Journal:  Value Health        ISSN: 1098-3015            Impact factor:   5.725


  17 in total

Review 1.  An Educational Review About Using Cost Data for the Purpose of Cost-Effectiveness Analysis.

Authors:  Matthew Franklin; James Lomas; Simon Walker; Tracey Young
Journal:  Pharmacoeconomics       Date:  2019-05       Impact factor: 4.981

Review 2.  Cost-Effectiveness Thresholds: the Past, the Present and the Future.

Authors:  Praveen Thokala; Jessica Ochalek; Ashley A Leech; Thaison Tong
Journal:  Pharmacoeconomics       Date:  2018-05       Impact factor: 4.981

3.  Strengthening health systems to improve the value of tuberculosis diagnostics in South Africa: A cost and cost-effectiveness analysis.

Authors:  Nicola Foster; Lucy Cunnama; Kerrigan McCarthy; Lebogang Ramma; Mariana Siapka; Edina Sinanovic; Gavin Churchyard; Katherine Fielding; Alison D Grant; Susan Cleary
Journal:  PLoS One       Date:  2021-05-14       Impact factor: 3.752

4.  A cost-utility analysis of small bite sutures versus large bite sutures in the closure of midline laparotomies in the United Kingdom National Health Service.

Authors:  Shyam Ajay Gokani; Karl O Elmqvist; Osman El-Koubani; Javier Ash; Sudeep K Biswas; Maxime Rigaudy
Journal:  Clinicoecon Outcomes Res       Date:  2018-02-19

Review 5.  Primary and secondary prevention interventions for cardiovascular disease in low-income and middle-income countries: a systematic review of economic evaluations.

Authors:  Leopold Ndemnge Aminde; Noah Fongwen Takah; Belen Zapata-Diomedi; J Lennert Veerman
Journal:  Cost Eff Resour Alloc       Date:  2018-06-14

6.  Health, financial, and education gains of investing in preventive chemotherapy for schistosomiasis, soil-transmitted helminthiases, and lymphatic filariasis in Madagascar: A modeling study.

Authors:  Jan-Walter De Neve; Rija L Andriantavison; Kevin Croke; Johannes Krisam; Voahirana H Rajoela; Rary A Rakotoarivony; Valérie Rambeloson; Linda Schultz; Jumana Qamruddin; Stéphane Verguet
Journal:  PLoS Negl Trop Dis       Date:  2018-12-27

7.  Striving for a Societal Perspective: A Framework for Economic Evaluations When Costs and Effects Fall on Multiple Sectors and Decision Makers.

Authors:  Simon Walker; Susan Griffin; Miqdad Asaria; Aki Tsuchiya; Mark Sculpher
Journal:  Appl Health Econ Health Policy       Date:  2019-10       Impact factor: 2.561

8.  Financing intersectoral action for health: a systematic review of co-financing models.

Authors:  Finn McGuire; Lavanya Vijayasingham; Anna Vassall; Roy Small; Douglas Webb; Teresa Guthrie; Michelle Remme
Journal:  Global Health       Date:  2019-12-18       Impact factor: 4.185

9.  Early intervention, treatment and rehabilitation of employees with common mental disorders by using psychotherapeutic consultation at work: study protocol of a randomised controlled multicentre trial (friaa project).

Authors:  Jeannette Weber; Peter Angerer; Lorena Brenner; Jolanda Brezinski; Sophia Chrysanthou; Yesim Erim; Manuel Feißt; Marieke Hansmann; Sinja Hondong; Franziska Maria Kessemeier; Reinhold Kilian; Christina Klose; Volker Köllner; Fiona Kohl; Regina Krisam; Christoph Kröger; Anja Sander; Ute Beate Schröder; Ralf Stegmann; Uta Wegewitz; Harald Gündel; Eva Rothermund; Kristin Herrmann
Journal:  BMC Public Health       Date:  2021-06-22       Impact factor: 3.295

Review 10.  Economic evaluations of alcohol prevention interventions: Is the evidence sufficient? A review of methodological challenges.

Authors:  Sarah R Hill; Luke Vale; David Hunter; Emily Henderson; Yemi Oluboyede
Journal:  Health Policy       Date:  2017-10-27       Impact factor: 2.980

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.